[11C]AZ-3391

N/A

Report date: 2025/11/21 17:15:35

NME

Base Information

Drug Name[11C]AZ-3391

Drug Alias Name[11C]AZ-3391

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Carbon > 11CRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionPoly (ADP-Ribose) polymerase 1 modulators

TargetsPoly (ADP-Ribose) polymerase 1

Therapy Area/IndicationsBrain metastases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAstrazeneca Plc

China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Plc

Inactive CompaniesN/A

Active IndicationsBrain metastases

Inactive IndicationsN/A

Other Information

ATC CodeN/A